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Abstract: Deoxynivalenol (DON) is one of the most commonly occurring trichothecenes, produced
mainly by Fusarium graminearum. Little is known about the effect of DON exposure or the levels
of DON exposure that occur during pregnancy. The project aimed to provide data on levels of
total DON and de-epoxi Deoxynivalenol (DOM-1) in pregnant human urine samples analysed by
liquid chromatography-mass spectrometry (LC-MS). Morning urine samples were collected over
two consecutive days from 42 volunteers and associated food consumption was recorded for the
24 h prior to the sample. Spearman’s rho non-parametric test for correlation was used to assess
the data. Levels of DON did not differ significantly between day 1 (mean 29.7 ng/mL urine or
40.1 ng DON/mg creatinine) and day 2 (mean 28.7 ng/mL urine or 38.8 ng DON/mg creatinine
ng/mL/day) urine samples. The only significant positive correlation was found between total ng
DON/mg creatinine and parity (rho = 0.307, n = 42, p < 0.005 two-tailed) and total ng DON/mg
creatinine with baked goods on day 1 (rho = 0.532, n = 42, p < 0.0005 two-tailed). This study provides
data on the DON levels in pregnancy in this suburban population and reassurance that those levels
are within acceptable limits.
Keywords: mycotoxins; Deoxynivalenol; pregnancy; vomitoxin
1. Introduction
Moulds of the genera Aspergillus, Penicillium and Fusarium naturally occur in grains and produce
mycotoxins that can contaminate cereal-based food and foodstuffs. Deoxynivalenol (DON) belongs
to a large group of mycotoxins named trichothecenes, which represent the main group of Fusarium
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toxins commonly found in cereal grains. Exposure assessment is an essential part of a risk assessment
of xenobiotic compounds (e.g., mycotoxins) through diets containing contaminated food. Cereal-based
foodstuffs are considered a major contributor to DON exposure. Therefore, the evaluation of DON
and DON metabolites in urine may constitute a valuable indicator of the dietary exposure. On the
basis of the available information derived from the toxicity studies, a temporary tolerable daily intake
(TDI) of 1 µg/kg body weight (b.w.) was established by the EU Scientific Committee on Food [1]
which was in line with the temporary tolerable daily intake established by the Nordic Group [2] and
World Health Organization [3]. In 2010, the Joint Expert Committee for Food Additives (JECFA) [4]
stated that, since metabolic studies indicated that DON acetylated forms are rapidly and extensively
de-acetylated to DON, contributing to the total DON-induced toxicity, the provisional maximum
tolerable daily intake (PMTDI) for DON could be converted to a group PMTDI of 1 µg/kg b.w. for
DON and its acetylated derivatives, 3-acetyl-deoxynivalenol (3Ac-DON) and 15-acetyl-deoxynivalenol
(15Ac-DON) [4]. The Committee also concluded that there was insufficient information to include
DON-3-glucoside in the group PMTDI. JECFA concluded also that DON is a probable factor for acute
pathologies in humans and derived an Acute Reference Dose (ARfD) of 8 µg/kg b.w.
Recent studies have demonstrated that consumption of DON-contaminated grain-based products
is associated with the presence of DON and its metabolites (e.g., DON-glucuronide) in human urine.
The available data show that the main fraction of this mycotoxin is excreted in the urine. DON is
detectable also in serum in high amounts immediately after ingestion, but is rapidly cleared from
the blood stream. So far, three major metabolites of DON have been identified in mammals: namely,
deoxynivalenol-3-glucuronide (DON-3-GlcA), deoxynivalenol-15-glucuronide (DON-15-GlcA) and
de-epoxi Deoxynivalenol, also known as DOM-1. Analytical methods with high sensitivity have been
developed and applied for precise quantification of DON and/or its metabolites in urine samples [5].
Little is known about the effect of DON exposure during pregnancy on the human foetus or the
levels of DON exposure that occur during pregnancy. During pregnancy the foetus is exposed to the
contaminants contained in the mothers’ diet. DON is known to cause a range of adverse effects in
animals and can cross the placental barrier. Research has shown that DON can transfer to the foetus
of pregnant sows [6] and has been linked to restrictions in both growth and immune function [7].
In swine, DON intake reduces weight gain and hinders animal feeding. Acute exposure of pigs to
DON at high concentrations (more than 10 mg/kg) causes abdominal distress, increased salivation,
malaise, diarrhoea, emesis [8,9] and some feed refusal [10]. Due to these effects, DON is also known
as vomitoxin. Given that DON can cross the placenta of animals [6] it is likely that in utero exposure
to DON will occur in humans. The detoxification capacity of the foetus will not be fully developed,
at a time of rapid growth and cell turnover [11], therefore pregnancy may represent a critical window
for DON exposure. Thus, the exposure of pregnant women to DON in the diet is of concern. This paper
affords a distinctive data set detailing the DON exposure of White Caucasian pregnant women in
a suburban setting, including females in their first trimester of pregnancy, providing data on levels of
DON in human urine samples collected from pregnant women in Hull, East Yorkshire, as analysed by
liquid chromatography-mass spectrometry (LC-MS).
2. Results
A total of 42 White Caucasian females were enrolled in the trial between May and October of
2014. Ages ranged from 20 to 38 years, with a mean of 28 years, and a standard deviation (SD) ±4.6.
The majority of females were in the second trimester of pregnancy (n = 23) with a mean gestational age
of 26 weeks. Only two females were in the first trimester and 17 were in the final trimester. Of the
42 pregnant women, 19 (45%) were pregnant for the first time, 13 (31%) had one previous pregnancy,
six (14%) had two previous pregnancies, three (7%) had three previous pregnancies and one (2%)
had experienced four or more previous pregnancies. The mean height was 1.65 m, with a range of
1.49–1.77 m, (SD) ±0.065, and the mean weight was 84 kg, with a range of 59–150 kg, (SD) ±19.47;
this equated to a mean BMI of 32 kg/m2 with a large range of 21–57 kg/m2, (SD) ± 7.2.
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Free DON (>LOD 0.12 ng/mL), and DON glucuronide (>LOD 0.25 ng/mL) were detected in
most of the urine specimens, whereas DOM-1 and de-epoxy DON glucuronide were not detected
(LOD 0.25 ng/mL).
Total DON (free DON and DON glucuronide combined) was detected in 88.1% (n = 37) of women
on day 1 and 83.3% (n = 35) on day 2. With respect to total DON, free DON and DON glucuronide
represented 12% and 88%, respectively, on day 1, and 16% and 84%, respectively, on day 2. Only three
of the pregnant females had no DON present in their urine on day 1 and day 2 of the study. Four
of the pregnant females had DON in their urine on day 1 of the study but not on day 2 of the study
and, conversely, two of the pregnant females had DON in their urine on day 2 of the study but not
on day 1 of the study. The mean values were obtained using the lower bound approach. On day 1
the mean level of total DON (ng/mL urine) (n = 42) was 29.7 (range 0–436), and on day 2 it was 28.7
(range 0–167) (See Figure 1a). In order to adjust the urinary total DON levels (ng/mL) for the effects of
fluid balance, the ng/mL of total DON was corrected for mg/mL of creatinine. Therefore, on day 1 the
mean level of ng total DON/mg creatinine (n = 42) was 40.1 (range 0–769), and on day 2 it was 38.8
(range 0–269) (See Figure 1b).
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Figure 1. Box plot of (a) unadjusted and (b) creatinine‐adjusted total DON concentrations in pregnant 
women’s urine samples for day 1 (blue) and day 2 (red) [12]. The band inside the box is the second 
quartile  (P50, median). Dots are suspected outliers. Whiskers are set  from minimum  to maximum 
value. The bottom and the top of the box are the first and third quartiles (P25 and P75). 
Figure 1. Box plot of (a) unadjusted and (b) creatinine-adjusted total DON concentrations in pregnant
women’s urine samples for day 1 (blue) and day 2 (red) [12]. The band inside the box is the second
quartile (P50, median). Dots are suspected outliers. Whiskers are set from minimum to maximum
value. The bottom and the top of the box are the first and third quartiles (P25 and P75).
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Due to the skewed nature of the data, non-parametric tests for correlation (Spearman’s rho) were
used for analysis. Tests for total DON (ng/mg creatinine) vs. weight, age, BMI, physical activity, week
of gestation, trimester and parity were performed. A significant positive correlation was only found
between total DON (ng/mg creatinine) and parity (rho = 0.307, n = 42, p < 0.005 two-tailed). Generic
associations between food consumption and urinary DON were assessed by ordered logistic regression
models. Tests were performed for total DON (ng/mg creatinine) vs. food intake (grams) for each of
the seven food categories on day 1 and day 2. The only significant correlation was found between total
DON (ng/mg creatinine) on day 1 with baked goods (rho = 0.532, n = 42, p < 0.0005 two-tailed). Baked
goods were defined as sweet biscuits such as digestives or hobnobs excluding fine bakery wares such
as croissants and cakes. Only one participant, a female, followed a vegetarian diet.
Based on the daily food diaries documented by participants in the 24 h prior to the first morning’s
urine sample, the most common cereal choice for pregnant females in Hull was wheat bran flakes.
Porridge high in bran was never consumed. Of the seven categories, bread provided the largest
contributor to the daily food intake, followed by pasta, then baked goods. Of the category “products
alternative to bread”, pizza was the most commonly consumed food. Plain dried (durum wheat)
pasta was the most commonly consumed food in the pasta category. Fresh egg pasta was the least
consumed food in the pasta category. No beer was consumed by any of the participants on day 1.
On day 2, two participants consumed lager; one consumed a medium portion (574 g = 1 pint) and one
consumed a small portion (287 g = 1/2 pint) [13]. On analysis of the Food frequency questionnaires
(FFQ), alcohol-free lager was more commonly consumed in comparison to standard lager.
3. Discussion
Mycotoxins contaminate up to 25% of the world’s cereal crops; the potential health consequences
of these exposures remain mostly poorly investigated [14]. The high incidence of DON in the urine
of UK pregnant females in this study (88% on day one and 83% on day two) confirms its ubiquitous
presence in cereal food products in the UK. This study provides distinctive findings describing the level
of DON in the urine of a cohort of White Caucasian pregnant women residing in Hull, East Yorkshire,
UK, at mean levels of 40.1 ng and 38.8 ng/mg creatinine on two separate days that are within the
recommended TDI [1].
Human research involving pregnant women in Bradford, West Yorkshire (60 miles west of the
current study), was carried out on 85 pregnant women as part of the Born in Bradford study (BIB).
The females provided urine samples during the last trimester of pregnancy; 34% of the women were
classified as being of South Asian origin. The distribution of urinary DON was similar to that reported
here, although some of the readings were the highest ever recorded in a study [15]. The GM urinary
DON level was 10.3 ng/mg creatinine (range of 0.5–43.3), with a marked difference between women of
South Asian origin where the GM was 15.2 compared to the non–South Asian GM of 8.6 ng DON/mg
creatinine, respectively [15]. In the Turner et al.’s (2008) study of the UK adult population, the GM
level of urinary DON after adjustment for creatinine was 8.9 ng/mg (95% CI, 8.2–9.7 ng DON/mg
creatinine; range 0.6–48.2 [16]. The GM for the Hull females was 11.72 ng DON/mg creatinine (range
of 0.01–769), similar to that in Bradford of 10.3 ng/mg creatinine [15]. It is suggested that a mean
urinary level of 9–10 ng DON/mg creatinine corresponded to an intake of roughly 20%–25% of the
recommended tolerable daily intake (rTDI) of 1000 ng/kg b.w. [1]. From this we can extrapolate that,
on average, the pregnant females in Hull were likely to be consuming safe levels of DON in their diet.
DON exposure may differ around the world. In Bangladesh, researchers found DON exposure
in pregnant women was significantly lower and more modest than previous results from Europe or
Asia [17]. This in part may be due to their diet habits, but it could not be deduced as FFQs were designed
to capture aflatoxins rather than DON, stating only that the contributors would predominantly include
wheat and maize if surveyed [18]. Piekkola et al. (2012) performed a cross-sectional assessment of
98 women, in their third trimester of pregnancy in rural Egypt [18], providing descriptive data on
the concentrations of DON, DOM-1 and aflatoxin biomarkers in urine and blood. This was the first
work of its kind to be carried out on an African population. They found the frequency and levels of
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these biomarkers in Egyptian women were modest, compared to other high-risk areas. DON was
only observed in 68% of the pregnant women’s urine and the GM of DON was 1.11 ng/mg creatinine
(range 0.6–24.3 ng/mg creatinine). These findings represent the lowest GM DON/creatinine of all the
findings discussed in this paper. The detection of DON in urine was also low in comparison to other
studies and similar to that of levels found in rural Bangladesh [16].
Pregnant females of Asian descent, living in suburban areas, appear to the highest levels of GM
DON/creatinine in their urine levels [15]. It is unclear whether this is due in some part to ethnicity,
living in a suburban area, diet consumed or all of the above. Pregnant women from the suburban areas
of Bangladesh had a significantly higher mean level of urinary DON (1.44 ± 2.20 ng/mL) than their
rural counterparts (0.47 ± 0.73 ng/mL). The researchers [16] attribute this to a higher consumption
of wheat breads in the suburban participants. It is suggested that white, wholemeal and other bread
cereals contributed significantly to DON levels in the diets of pregnant and non-pregnant females
from the general UK population [5,15]. The higher intake of chapattis by women of South Asian
origin was attributed to the higher level of DON when compared with women of non-South Asian
origin (GM 15.2 vs. 8.6 ng DON/mg creatinine, respectively). For the pregnant females in Hull the
only significant correlation was found between ng total DON/mg creatinine on day 1 with baked
goods [12]. Baked goods are defined as sweet biscuits such as digestives or hobnobs, excluding fine
bakery wares such as croissants and cakes.
Adjusting for individual bodyweight and assuming daily urine excretion of 2 L and DON excretion
rates of 68%, the provisional daily intake (PDI ng/kg b.w.) could be assessed utilizing the calculations
described by Ali et al. [16]. Urinary DON levels were much higher in pregnant women from Hull
compared to Bangladeshi ones (both from rural and suburban areas): values of 29.7 ng/mL, (SD) ±69.3,
for day 1 and 28.7 ng/mL, (SD) ±42.5, for day 2 in Hull when compared with average values of
0.86 ng/mL, (SD) ±1.57, in Bangladesh. Consequently, mean PDI levels were much higher for Hull
than for Bangladeshi women. Therefore, while the entire population in Bangladesh would be far
from the rTDI of 1000 ng/kg b.w., 25% of the Hull group would exceed the rTDI according to these
calculations (75th percentile being 1012.4 ng/kg b.w. for day 1 and 1254.8 ng/kg b.w. for day 2) and
the 95th percentile would exceed the rTDI by a factor of three times and five times for day 1 and day 2,
respectively. This scenario may be a reason for concern, especially for this specific vulnerable group of
the population, and may give the opportunity for reconsidering the toxicological threshold and/or
legal limits. However, the 50th percentile of the Hull group (being set to 411.2 ng/kg b.w. for day 1
and 399.5 ng/kg b.w. for day 2) is below the rTDI.
A 24 h food diary is a quick, cheap and simple method for performing dietary analysis. However,
variability can occur between oral intakes day to day [19]. To counteract this, two consecutive 24 h
food diaries were used for this study. A semi-quantitative FFQ was utilised to record the participants’
previous month’s food intake, portion size and whether or not the food was organic. Food frequency
questionnaires are thought to provide estimates of habitual intake and are widely used in nutritional
epidemiology [20,21]. The length and complexity of the FFQ can influence the response to dietary
recording. Two advanced research dietitians were responsible for performing the semi-structured
interviews on all participants in the study. The interviewing and counselling skills of the experienced
research dietitians will have removed a degree of potential error from the data recorded.
The limitations of the study include the small sample size of 42 women and no organic foods
being eaten by the pregnant females in the study; consequently, organic food as a variable could
not be analysed fully due to the absence of data. The lack of organic food consumed is likely to be
secondary to the deprived nature of the population studied. In order to assess the effect of organic
food consumption, a fit for purpose study should be designed to consider organic food consumers
as a category. Portion size can represent a major source of uncertainty for food items contributing to
DON exposure. Documentation of actual weights consumed could have improved the accuracy of the
food data recorded ready for correlation with DON concentration in urine. To obtain a more accurate
estimation of the carry over of DON from ingested food to urine, 24 h urine collection rather than
a single first morning urine sample would be desirable.
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Very few studies have been conducted so far in the population subgroup of pregnant women and
little is known about the consequences of exposure. Future large-scale studies with multi-site analysis
are required to give a more varied population sample to extrapolate results.
4. Conclusions
In conclusion, this study provides data on the DON levels in pregnancy in this suburban
population and it is reassuring that 50th percentile is within acceptable and safe limits. However,
it should be appropriate to consider a revision of the TDI and/or DON maximum limits and to
set additional agricultural strategies to minimize the exposure, improving the quality of wheat raw
materials. Finally, an appropriate information program given by physicians would help to orient the
dietary habits of UK pregnant women and protect this vulnerable group, also in consideration of the
potential of toxin transfer to the foetus.
5. Experimental Section
5.1. Ethics
Ethical approval was granted by the National Health Service (NHS), National Research Ethics
Service (NRES) Committee Yorkshire & the Humber—Leeds West on the 11 April 2014. IRAS project
code 147707. SPSS IBM 23 and Microsoft excel 2013 were used to analyse the data.
Recruitment
Pregnant women were recruited by accessing weekly antenatal clinics at Hull Royal Infirmary.
Recruitment took place between May and October 2014. Participants were also recruited by placing
an approved advertisement in the local papers and an email “shot” via the University of Hull and Hull
and East Yorkshire Hospitals NHS portal.
The pregnant females were required to be in good health, taking no medication or on stable
medication. For the purpose of this study, stable medication was defined as medication taken for
more than three months, however the medication prescribed even if stable must not affect appetite,
e.g., oral steroids. Exclusion criteria included inability to give informed consent/complete the
questionnaire, acute pathologies, chronic illness (chronic renal, hepatic or cardiac problems, cancer),
chronic gastrointestinal conditions (e.g., coeliac disease), gluten sensitivity, eating disorders, following
a weight loss diet, depression, psychosis or hospitalisation within three months of enrolment in
the trial.
5.2. Methods
The data utilised in this study is extracted from a larger study to answer a call from the
European Food Safety Authority (EFSA) GP/EFSA/CONTAM/2013/04 into the Experimental study
of deoxynivalenol biomarkers in urine [12]. The study collected data on the occurrence of DON and its
metabolites in urine from European population groups, namely children, adolescents, adults, elderly,
vegetarians (defined as following the diet for >1 year) and pregnant women and to develop reliable
information on the associations between concentrations of DON in urine and self-reported cereal
food consumption in the investigated subjects. A total of 635 volunteers were recruited across three
European countries, i.e., Italy, Norway and the UK. This paper focuses on the pregnant subset of data
in the UK.
Age, height, ethnicity, weight, physical activity level, week of gestation, parity, and any dietary
restriction was recorded using FFQ. The FFQ comprised of 61 cereal-based food items, split into seven
different food categories, all considered to contribute to the consumption of DON. The food categories
included breakfast cereals and snacks, bread, products alternative to bread, pasta, biscuits and bakery
products, cereals and similar and beer. The research dietitians conducted a semi structured interview
to record the intake of each food category consumed over the last month, the size of said portion and
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whether the food was organic. The FFQ featured photographic examples of portion sizes to aid the
participants in the quantification of the food consumed. The basis for the FFQ was the recent validated
questionnaire used in a Spanish study targeted to pregnant women [22] and the National Health
and Nutrition Examination Survey (NHANES) FFQ [23]. The urine collection method was explained
to each participant by the Research dietitian or Research nurse. Participants were provided with
a collection container, 4× urine sample pots (50 mL) and written instructions for urinary collection at
home. The participants were asked to provide a sample of first morning urine, in their own home, on
two consecutive days and decant the urine from the bottle into 2 × 50 mL pots on each day. A 24 h
food diary was documented by the participant over two consecutive days (on the days prior to each
collection of their first morning urine sample). The 24 h food diary consisted of sections for breakfast
lunch, dinner and snacks. Within each meal group, examples of food taken from each food category
were tabulated with tick boxes provided to allow ease of recording as to whether the portion was
small, medium, large or organic. The urine samples were returned to the clinical trials unit on the same
day and centrifuged immediately at the Hull Royal Infirmary (Hull, UK), in a refrigerated centrifuge
at 2000 rpm for 10 min. The samples were then pipetted into a transfer container leaving a small
amount of urine behind therefore excluding any debris. The samples were then frozen at −80 ◦C
and the freezer temperature was monitored regularly. One sample from each day was sent to Leeds
University (Leeds, UK) for analysis in batches and the other sample were stored at the clinical research
unit in Hull as a reserve in case of loss or damage to the primary sample whilst being transported to
Leeds University.
Analysis of Urine samples for DON and its metabolites were carried out utilising the validated
HPLC-MS/MS methodology developed at Leeds University [5]. The levels of the subjects in the UK
were measured in urine samples in two steps. In brief, urine samples (mainly around 10 mL) were
removed from storage at −20 ◦C, allowed to thaw, and centrifuged (2000 rpm; 15 min; 4 ◦C). Aliquots
(1 mL) were mixed with 13C-DON internal standard solution, to give a final concentration of 20 ng/mL.
5.2.1. Aliquot 1
Total DON detection (free DON and glucuronide metabolites combined): To measure free
DON and combined glucuronide metabolites of DON (deoxynivalenol-3-O-glucuronide and
deoxynivalenol-15-O-glucuronide), each sample was adjusted to pH 6.8 and digested using
β-glucuronidase solution (23,000 units, in KH2PO4 75 mM) in a shaking water bath for 18 h at 37 ◦C.
After this period, the samples were removed, centrifuged (2000 rpm; 15 min; 4 ◦C), and the supernatant
diluted to a final 4 mL with phosphate buffered saline (PBS, pH 7.4). The diluted urine sample
was then passed through a wide bore DON immunoaffinity column, following the manufacturer’
instructions. DON was eluted from columns with methanol (4 mL) and extracts dried under vacuum
using a SavantTM SpeedVacTM (Thermo Fisher Scientific Inc., Waltham, MA, USA) or equivalent and
reconstituted in 10% ethanol (250 µL) for LC-MS analysis.
DOM-1 was quantified on the same aliquot analysed for DON glucuronide. In fact, the available
data, coming from previous experience, indicate that urinary digestion using β-glucuronidase is able
to release DOM-1 quantitatively.
5.2.2. Aliquot 2
Free DON detection: the free amount of DON was extracted as before but omitting the
β-glucuronidase treatment.
5.2.3. LC-MS Analysis—DON Determination
Separation of DON was achieved using reversed phase chromatographic columns and a mobile
phase sequence of 27 min 20% methanol, changing to a wash of 75% methanol after 10 min and
reverting to 20% methanol after 16 min (flow rate 1 mL/min; injection volume 25 µL). One-fifth
of the eluent was directed into the desolvation chamber of the MS and the remainder pumped to
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waste. Selective ion recording (SIR) was used to quantify DON by reference to 13C-DON internal
standard. Two masses both of DON ([DON-H]+, m/z 297.2 and [DON-Na]+, m/z 319.2) and 13C-DON
([13C-DON-H]+, m/z 312.2 and [13C-DON-Na]+, m/z 334.2) were monitored for 0.25 s each and
summed to produce one total ion current peak for each analyte and internal standard. The calibration
curve was set by the injection of DON and 13C-DON standard solution (prepared in 10% ethanol)
covering the range 2–250 ng/mL.
In addition to measuring free DON and total DON, DON glucuronide values were calculated as
the difference between total DON and free DON values for each individual.
5.2.4. LC-MS Analysis—DOM-1 Determination
Separation of DOM-1 was achieved using the same chromatographic column used for DON and
a mobile phase sequence of 35 min 20% methanol, changing to a wash of 75% methanol after 20 min and
reverting to 20% methanol after 26 min (flow rate 1 mL/min; injection volume 25 µL). One-fifth of the
eluent was directed into the desolvation chamber of the MS and the remainder pumped to waste. SIR
was used to quantify DOM-1 by reference to the calibration curve, obtained by the injection of DOM-1
standard solutions (prepared in 10% ethanol) covering the range 2–200 ng/mL, using least squares
regression analysis. Two masses of DOM-1 ([DOM-1-H]+, m/z 281.3 and [DOM-1-Na]+, m/z 303.3)
were monitored for 0.25 s each and summed to produce one total ion current peak for DOM-1.
5.2.5. Creatinine Analysis
Since only first morning samples of urine were collected, levels of DON were adjusted for
creatinine to correct for variable dilutions. Urinary creatinine analysis was conducted for all samples
using an in-house micro-titre plate assay as previously described and modified from the alkaline-picrate
method [15]. In brief, urine samples were diluted in water (1:20) and 100 µL loaded into a 96-well plate,
in duplicate. A duplicate standard curve of creatinine concentrations was used per plate ranging from
0 µg/mL to 20 µg/mL. 100 µL of alkaline picric acid solution was then added to each well, incubated
at 25 ◦C for 30 min and read at 490 nm using a plate spectrophotometer.
Results were presented both corrected and uncorrected for creatinine as Total DON ng/mL urine
and as g total DON ng/mg creatinine in urine. The latter allow a correction for different degrees of
dilution of the urine between individuals.
5.2.6. Dietary Analysis
The research dietitians converted the portion sizes documented into the FFQ and food diaries
to actual quantities (grams) prior to their entry into the FoodEx2 coding system [13,24]. FoodEx2
(revision 1) is a comprehensive food classification and description system aimed at covering the need
to describe food in data collections across different food safety domains issued by EFSA. Central to the
system is a core list of food items or generic food descriptions that represent the minimum level of
detail needed for intake or exposure assessments [25]. The FoodEx2 code number for each food was
retained and included in the database including the results from the FFQ. A harmonized database was
developed to collect all the data related to the enrolled subjects concerning individual information
(age, gender, BMI, and other information), urine testing results and food intake. In total, the UK FFQ
comprised of 61 cereal based food items, each food corresponded to a FoodEx 2 code, e.g., A008K.
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